Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Cloud-Based Rare Disease Family Registry Market Growth Potential: How Will Market Size Shift Through 2030?
The cloud-based rare disease family registry market size has seen swift expansion in recent years. This market is set to expand from $1.4 billion in 2025 to $1.65 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.7%. The growth observed in prior periods can be linked to the proliferation of rare disease research initiatives, augmented patient advocacy involvement, the widening of clinical trial networks, the increasing uptake of electronic data capture tools, and the necessity for centralized patient data systems.
The cloud-based rare disease family registry market is projected to experience swift expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $3.15 billion, demonstrating a compound annual growth rate (CAGR) of 17.5%. This projected growth is driven by several factors, including escalating investments in orphan drug development, a heightened demand for real-world evidence generation, the broadening scope of precision medicine research, the increasing adoption of ai-driven data analytics, and a greater focus on patient-centric research models. Key trends expected during this period involve the increasing embrace of cloud-based patient registries, the expanded utilization of digital platforms for rare disease research, the deepening integration of genomic and clinical data, the growth of global clinical trial recruitment tools, and a sharpened focus on secure data sharing.
Get A Free Sample Report With In-Depth Market Insights:
Cloud-Based Rare Disease Family Registry Market Growth Backed By Core Demand Fundamentals
The expanding focus on precision medicine is projected to stimulate the growth of the cloud-based rare disease family registry market in the future. Precision medicine is a healthcare approach that customizes treatment and prevention strategies to align with an individual’s genetic, environmental, and lifestyle factors. This increase in precision medicine stems from advancements in genomic sequencing, which allow medical professionals to more accurately decipher patients’ genetic makeup. Cloud-based rare disease family registries facilitate precision medicine by compiling and centralizing extensive patient data, encompassing genetic, clinical, and treatment information. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, documented that in 2023, the Food and Drug Administration (FDA), a US-based federal agency, authorized 16 novel personalized therapies for patients with rare diseases, representing a notable increase from the six approvals in 2022; among these newly sanctioned treatments, seven are directed at cancer, while three are focused on other diseases and conditions. Therefore, the heightened emphasis on precision medicine is driving the expansion of the cloud-based rare disease family registry market.
Cloud-Based Rare Disease Family Registry Market Segment Analysis And Revenue Potential
The cloud-based rare disease family registry market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment Mode: Public Cloud, Private Cloud, Hybrid Cloud
3) By Application: Patient Data Management, Research, Clinical Trials, Genetic Data Collection, Other Applications
4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Patient Advocacy Groups, Other End-Users
Subsegments:
1) By Software: Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System
2) By Services: Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades
Cloud-Based Rare Disease Family Registry Market Growth Trends Reshaping The Competitive Landscape
Major companies in the cloud-based rare disease family registry market are pushing forward with technological innovations, such as bilingual federated registries, to provide secure, multi-location data platforms for patients, families, and researchers. These platforms are designed to enhance participation and support real-time data collection and analysis. A bilingual federated registry is a cloud-based system that allows data to remain at local sites while accommodating multiple languages and complying with regional consent and privacy regulations. For instance, in June 2025, the National Organization for Rare Disorders (NORD), a U.S.-based nonprofit, announced plans to launch two Canadian patient registries for PKU and MPS. These registries, developed in partnership with Canadian patient advocacy groups, researchers, and clinicians, mark the first time the IAMRARE Program will be hosted outside the U.S. Their purpose is to adhere to provincial consent requirements, enable cooperative real-time data collection and analysis, and support efforts to accelerate research, improve the understanding of rare metabolic disorders, and facilitate the identification of participants for clinical trials.
Cloud-Based Rare Disease Family Registry Market Key Players Shaping Industry Direction
Major companies operating in the cloud-based rare disease family registry market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., ICON plc, Syneos Health Inc., Parexel International Corp., Medidata Solutions Inc., FIGMD Inc., OM1 Inc., Mission Health Labs Inc., TREAT-NMD Global Registries Platform, Seqster PDM Inc., ArborMetrix Inc., OpenClinica LLC, Pulse Infoframe Inc., Oracle Healthcare Pvt. Ltd., QuesGen Systems Inc., FTD Disorders Registry, Castor LLC, Data Registry Services LLC, Fibrolamellar Registry, Rare Central
View The Full Cloud-Based Rare Disease Family Registry Market Report:
Cloud-Based Rare Disease Family Registry Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the cloud-based rare disease family registry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cloud-based rare disease family registry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.